APAAACIAPAAACIAPAAACI

Welcome to APAAACI

The Asia Pacific Association of Allergy, Asthma and Clinical Immunology (APAAACI) is an association of National/Regional societies of Allergy and Clinical Immunology in the Asia Pacific region. In countries where no such society exists, individual medical practitioners who have made a significant  contribution to the field of Allergy, Asthma or Clinical Immunology may be admitted as members.

APAAACI Individual Membership

Annual Membership Fee USD 50/- 
APAAACI extends several privileges to its individual members.

Upcoming Events

Stay updated with our latest events.

APAAACI International Conference 2023

Organized by Asia Pacific Association of Allergy, Asthma and Clinical Immunology (APAAACI) & Allergy and Clinical Immunology Society of Singapore (ACIS).

APAAACI Journal

Asia Pacific Allergy (AP Allergy) is the official journal of the Asia Pacific Association of Allergy, Asthma and Clinical Immunology (APAAACI).

APAAACI CENTERS OF EXCELLENCE

We are excited to announce that the application submission is now open for the APAAACI Centers of Excellence (ACE). The ACE is designed to recognize multidisciplinary academic medical institutions/centers in the Asia Pacific region and beyond, that are actively promoting innovation, education, research, and advocacy in allergy, asthma, and clinical immunology.

The ACE will create a platform for researchers and clinicians delivering excellence in education, training, research and patient care in allergy, asthma and clinical immunology.

Merits of becoming an ACE
  • Opportunity to collaborate with APAAACI on educational programs, resources, committees and congresses
  • Scientific support in the development and dissemination of publications / educational resources
  • Cross collaboration with other Centers of Excellence regionally and globally to form international multi-Center projects, joint mentorship, research fellowships
  • ACE recognition award plaque

Latest Newsletter

Stay ahead in a rapidly changing world. Subscribe to our Insights.